Before you sell to, join or invest in AI3 Bio, Inc.
MentionFox check on AI3 Bio, Inc.: only 1 source on file so far (checked 5 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/ai3-bio-inc-form-d-000003
Check AI3 Bio, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about AI3 Bio, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
AI3 Bio, Inc. filed a Form D with the Securities and Exchange Commission on 2026-11-04.
AI3 Bio, Inc. filed a Form D notice of an exempt securities offering with the SEC on November 4, 2026. AI3 Bio, Inc. was formerly named Corner Therapeutics, Inc. The filing reports $48.34M sold. Its industry group is Biotechnology. It names Steven Altschuler (Executive Officer, Director), Michael Lyman (Executive Officer), Nick Seaver (Executive Officer, Director) (SEC Form D, November 4, 2026).
AI3 Bio, Inc. raised on Nov 4. 125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like AI3 Bio, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-11-04 · the record
Pitching, partnering or investing alongside them? See who really runs and owns AI3 Bio, Inc.
Free to see. No signup.
More on the people and the money behind AI3 Bio, Inc., from the filings we hold.
Biotechnology raises by companies based in Massachusetts, filed within 90 days of this one, largest first.
Get an email when AI3 Bio, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when AI3 Bio, Inc. raises, hires or launches. No email unless you switch it on.
Watch AI3 Bio, Inc. →Get the full cited report on AI3 Bio, Inc.
What the filing shows about AI3 Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on AI3 Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives AI3 Bio, Inc.'s address as 99 Coolidge Ave, Suite 201, Watertown, MA 02472.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for AI3 Bio, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
AI3 Bio, Inc. is a registered filer with the SEC (CIK 2019875) and has filed since 2024-04-23. 6 filings are on record, the latest on 2026-11-04.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
AI3 Bio, Inc.'s Form D of 2026-11-04 names Steven Altschuler, Michael Lyman, Nick Seaver and 4 more as its officers, directors or promoters.
Its new offerings report $116.04M sold across 3 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 765 filings in Biotechnology, totalled by week. The dot is this raise, $48.34M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Steven Altschuler is named as Executive Officer and Director on the Form D that AI3 Bio, Inc. filed with the SEC on 4 November 2026, one of 7 people that filing names.
Michael Lyman is named as Executive Officer on the Form D that AI3 Bio, Inc. filed with the SEC on 4 November 2026, one of 7 people that filing names.
Nick Seaver is named as Executive Officer and Director on the Form D that AI3 Bio, Inc. filed with the SEC on 4 November 2026, one of 7 people that filing names.
Fabian Tenenbaum is named as Director on the Form D that AI3 Bio, Inc. filed with the SEC on 4 November 2026, one of 7 people that filing names.
Jeanne Cunicelli is named as Director on the Form D that AI3 Bio, Inc. filed with the SEC on 4 November 2026, one of 7 people that filing names.
Alan Ezekowitz is named as Director on the Form D that AI3 Bio, Inc. filed with the SEC on 4 November 2026, one of 7 people that filing names.
Jonathan Kagan is named as Executive Officer on the Form D that AI3 Bio, Inc. filed with the SEC on 4 November 2026, one of 7 people that filing names.
7 people named on the filing — 4 holding an executive role and 3 as directors only.
Named as of the 2026-11-04 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about AI3 Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on AI3 Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on AI3 Bio, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist AI3 Bio, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind AI3 Bio, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for AI3 Bio, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Boston raises, week of 2026-11-02 · Biotech raises, week of 2026-11-02 · Biotech raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/ai3-bio-inc-form-d-000003